Reported Dec 6, 2017 · Terminated

Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICALS IND, LTD,…

Teva Pharmaceuticals USA

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Teva Pharmaceuticals USA · 1090 Horsham Rd · North Wales, PA · 19454-1505

Is this the product you have?

  • Clozapine Tablets USP, 100 mg, 500 count bottles, Rx only
  • Manufactured in Israel byTEVA PHARMACEUTICALS IND, LTD, Jerusalem Israel
  • Manufactured ForTEVA PHARMACEUTICALS USA, North Wales, PA, NDC 00093-7772-05
Lot codes and dates
    • Lot # 39C192
    • exp 06/2019
Amount recalled
3,870 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed Tablet/Capsule Specifications; potential presence of broken tablets.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Teva Pharmaceuticals USA recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Jul 3, 2018 · Data as of Sep 19, 6:32 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.